Kimberly-Clark announced Monday morning that it agreed to buy Tylenol maker Kenvue for $48.7 billion, making the newly combined company one of the largest in the consumer health space.
Executives said the acquisition created a new “global health and wellness leader” able to generate up to $32 billion in annual revenue. The manufacturer of Tylenol has now joined the owner of brands such as Kleenex tissues and Huggies diapers.
In a press release, Kimberly-Clark Chairman and CEO Mike Hsu said his company is confident “that we will drive significant value for our combined shareholders.”
Kimberly-Clark shareholders will own 54% of the combined company, and Kenvue shareholders will own the remaining 46%. The transaction is set to close in the second half of 2026.
Kimberly-Clark’s shares were down 12.5% in premarket trading on Monday morning, while Kenvue’s shares were…




